Guangzhou-Israel Biotechnology Fund
Tracked across 1 events · 7 articles · First seen Jun 01, 2026 · Last active Jun 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Guangzhou-Israel Biotechnology Fund invested $8 million in ADMA Biologics and formed a joint venture to leverage its expertise in the Chinese biotechnology ecosystem, aiming to accelerate clinical development and expand Biond's pipeline in China.
Jun 01, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Guangzhou-Israel Biotechnology Fund live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard